22 Oct 2021

Pathway To Overcome Primary Packaging & Drug Product Manufacturing (F&F) Challenges: Case Study, Ophthalmic Drugs

This webinar will address:

  • The global ophthalmic drug market is forecasted to reach $47.6 billion by 2030 with a growth driven by the rapidly ageing global population.
  • Silicon oil-free technology contributes to achieve low subvisible particles and enable consistent and predictable glide forces for a better drug product system.
  • The collaboration on fill & finish processes and primary containers contribute to improve filling accuracy, minimize headspace and maximize throughput while ensuring flexibility and time to market.
  • Established collaboration such as Terumo and Swissfillon offers a best-in-class solution for ophthalmic projects

This webinar originally aired as part of Pharmapack Europe 2021

Content provided by our supplier

Terumo Europe NV - TPS

  • BE
  • 2015
    On CPhI since
  • 3
  • 500 - 999
Company types
Primary activities
Medical Devices

Other Content from Terumo Europe NV - TPS